Effect of N-acetyl cysteine on hepatitis risk reduction after anesthesia
Phase 3
- Conditions
- liver toxicity.Toxic liver disease
- Registration Number
- IRCT2014091919199N2
- Lead Sponsor
- Arak University of Medical Sciences, Vice chancellor for research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
age between 20 and 60 years old; ASA I or II; Elective surgery took 1-3 hours(except surgery on the liver and biliary tract). Exclusion: Underlying cardiovascular, pulmonary , renal , hepatic , endocrine diseases; Taking warfarin , aspirin , NSAIDS, vitamins, corticosteroids, Immuno-Suppressive Drug or any medications interfere with liver function;History of drug abuse, alcohol, cigarettes; History of hepatitis C, B; History of IBD, malabsorption; history of abdominal surgery 5 years ago.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method